In a mouse model of KP mutant lung cancer, neurotrophic tyrosine receptor kinase 1 (NTRK1) expression increased significantly after treatment with a PD-1 inhibitor, and NTRK1 promoted abnormal JAK1 and STAT3 activation. The gene discussed is NTRK1; the disease is lung carcinoma.